Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 19.3817.5940.03-17.601.84

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 19.38 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202619.38
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 19.38
10.18
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹60,398.0 Cr 2.6% -2.3% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

2.6%

-2.3%

-8.3%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses